Discover the latest insights from the TOReTO study on COPD management: Dual bronchodilator therapy has been shown to reduce exacerbations, with varying efficacy between current and former smokers.

A new study suggests COPD patients experience improved lung function and breathlessness after direct switch from long-acting bronchodilators or steroid containing combination therapies to ...

Formoterol (brand names Perforomist, Foradil) is a bronchodilator in a class of medications called long-acting beta agonists (LABAs). It is used to control wheezing, shortness of breath, coughing and ...

When used for this purpose, clenbuterol is considered a long-acting bronchodilator with a drug half-life of up to 48 hours. In the United States, clenbuterol is not approved for use in humans and is ...

The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...

The severe asthma market is fueled by the rising prevalence of the condition, particularly in urban areas, alongside the emergence of innovative therapies ...

Tiotropium, the first-choice long-acting bronchodilator in COPD, has been studied in severe asthmatics and in COPD patients with a history of asthma, showing an additional bronchodilator effect on ...

Diwali is synonymous with fireworks but such celebrations contribute to air pollution by releasing particulate matter (PM10 ...

American Thoracic Society guidelines recommend that people with moderate or severe COPD who experience shortness of breath and/or exercise intolerance receive a combination of two different types of ...

Long-Term Control Medicine reduces the swelling and inflammation in your airways and prevents symptoms You need to take these medicines every day, even when you feel well. The following medicines are ...